Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.
6th World Congress on Bioavailability & Bioequivalence: BA/BE Studies
The main theme of the conference is Advance Approaches in Discussion of Current Issues & Future Possibilities in Bioavailability and Bioequivalence Studies
2015-07-17 - 2015-08-19
Event contact title
Event contact first name
Event contact last name
Event contact telephone number
The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners. The global market for generic drugs was worth $81 billion in 2008, $84 billion in 2009, estimated to be $168.7 billion in 2014. Sales of U.S. generic drugs currently dominate the market with $54 billion for the 2014. Japan’s generic drugs market is expected to have the highest rate of growth among major markets at 12.2%, increasing from $5.4 billion in 2009 to $9.6 billion in 2014. By 2016, it is expected that the value of the total global generics sector will have risen to $358 billion. The North American market is estimated to reach to reach nearly $107 billion in 2016 with an increase of 7.9% compound annual growth rate annual growth rate and Emerging market to reach nearly $115 billion.